Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 287 | 2,389 | 3,540 | 2,784 | 407 |
| Marketable Securities | 10,012 | 11,012 | 11,509 | 15,234 | 19,362 |
| Other current assets | 0 | 266 | 596 | 582 | 0 |
| TOTAL | $10,899 | $13,666 | $15,645 | $18,600 | $20,473 |
| Non-Current Assets | |||||
| PPE Net | 524 | 233 | 199 | 211 | 42 |
| Other Non-Current Assets | 4 | 196 | 204 | 200 | 197 |
| TOTAL | $527 | $429 | $403 | $411 | $239 |
| Total Assets | $11,426 | $14,095 | $16,048 | $19,010 | $20,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,804 | 2,264 | 1,889 | 1,902 | 1,661 |
| TOTAL | $1,804 | $2,264 | $1,889 | $1,902 | $1,661 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,804 | $2,264 | $1,889 | $1,902 | $1,661 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 1 | N/A |
| Common Shares | 208 | 207 | 207 | 207 | 207 |
| Retained earnings | -75,035 | -72,629 | -70,138 | -66,904 | -64,782 |
| Other shareholders' equity | 131 | 225 | 88 | 200 | 20 |
| TOTAL | $9,623 | $11,831 | $14,159 | $17,108 | $19,051 |
| Total Liabilities And Equity | $11,426 | $14,095 | $16,048 | $19,010 | $20,712 |